₹851 Crore Disconnect: YoY Momentum vs. Sequential Reality
Q1 delivered 26.6% YoY revenue growth and FY27 disbursement guidance was raised 30% to ₹65k Cr—but sequential PAT halved and spreads compressed vs. guidance. The call reconciles the gap, but surfaces a harder question: whether execution risk is being underpriced.
₹3717.2 Cr
+26.6% YoY · +4.3% QoQ
₹851.1 Cr
+35% YoY · -57% QoQ
1.8%
vs 2% guided; compression flagged temporary
₹65,000 Cr
+30% vs ₹50k Cr achieved prior FY
HUDCO's Q1 print hits a classic market disconnect: top-line momentum (26.6% YoY revenue) and an upgraded full-year target look compelling, but sequential net profit fell 57%—enough to trigger a 3.81% sell-off on day 1. The stock remains oversold at RSI 27.9, sitting 20.96% below its all-time high and below all three major moving averages. But the move faded to -2.5% by day 3, as the earnings call clarified that the sequential PAT collapse stems from prior-year FCNR non-recurring gains ending, not operational failure. The real question is tougher: whether HUDCO can execute the raised FY27 target and recover spreads to guidance while building toward a ₹3 lakh crore loan book by 2030.
The FCNR gain haircut and why Q1 is operationally cleaner than it looks
Sequential PAT fell from ₹2,000 Cr (Q4 FY26) to ₹851 Cr—a real decline, but explained. Prior quarters benefited from non-recurring FCNR fair-value gains that have now lapped out. The call data supports management's core claim: Q1 is operationally clean because FCNR maturities are zero in FY27 and FY28, with only $200 million due in 2028 (hedged). This matched the prior guidance, so the sequential decline is not deterioration—it is the anniversary effect of a one-time item exiting.
No FCNR maturities in FY27/28. Only $200M maturing 2028, hedged. No forex losses expected. Prior guidance met.
The operational story is cleaner: revenue +26.6%, margins stable (OPM 97.1%, NPM 22.8%), credit exceptional (net NPA ₹82 Cr near-zero). What does NOT hold up is spreads guidance.
Where management's claims stand
FCNR issues behind us; no FY27/28 exposure
Loan book growth ~25% ongoing
Spreads will maintain at 2% mid-term
NIMs around 3% annually
Sanction pipeline ₹2.5L Cr available
FY27 disbursement ₹65k Cr (raised from ₹50k Cr prior year)
The spreads claim is the one that matters most and misses hardest. Q1 spreads landed at 1.8% vs. the guided 2%—a 20 basis point compression that management attributes to accelerated growth driving lower-yielding business. They argue recovery by Q3 as new Q4/Q1 disbursements capitalize. This is credible as a mechanism but unproven as a timeline—if spreads stay at 1.8% through Q3, the entire 3% NIM thesis weakens and long-term 25% loan book CAGR profitability comes into question.
What changed on this call
₹65,000 Cr
Raised from ₹50k Cr; 30% acceleration
Resolved
No maturities FY27/28; $200M in 2028 hedged
1.8% → 2% by Q3
Recovery timeline: Q3 (unproven)
₹3 lakh Cr
Reaffirmed; not upgraded despite visible pipeline
The disbursement raise signals management confidence in MOU execution—₹15k Cr incremental disbursements vs. ₹50k Cr prior year is a 30% lift. The board-approved borrowing plan of ₹70k Cr underpins this. The real test: can the ₹2L Cr+ visible MOUs (Gujarat >₹1L Cr urban infrastructure; Bihar >₹1L Cr satellite towns, roads, tourism, metro) translate to sanctions and disbursements fast enough? Note that management did not upgrade the ₹3L Cr by 2030 loan book target despite analyst Sumeet Rohra pressing on conservatism; management acknowledged the math looked right but held firm, citing execution risk (land acquisition, political approvals, 5-year project cycles add 1-2 year delays). That caution is worth noting.
How the market has positioned itself
The 3.81% day-1 sell-off was driven by institutional conviction (37.4% delivery rate), suggesting real concern about the sequential PAT collapse and spreads compression. The move faded to -2.5% by day 3 as the call detail clarified that FCNR gains are the culprit, not operations. The stock remains oversold: at ₹195.1 it sits 20.96% below its all-time high, below SMA20/50/200, with RSI 27.9 in oversold territory. Ownership is stable: promoters hold 75% (unchanged), DIIs at 11.03% (slight -0.43pp last quarter), FIIs at 2.22% (+0.25pp). The FII uptick is a micro signal of institutional nibbling into the drawdown. This positioning—oversold technicals, promoter indifference, cautious domestic flows, nibbling foreign buyers—suggests the market sees structural value but needs execution proof before reinvesting.
The bull-bear ledger
Urban infrastructure boom is structural tailwind (20+ year horizon); government policy backing is real
₹2L Cr+ visible MOU pipeline (Gujarat + Bihar) toward ₹3L Cr by 2030 target; 25% CAGR credible
55-year track record; state-backed with lower cost of capital; credit quality exceptional (net NPA ₹82 Cr)
Spreads compressed to 1.8% vs. 2% guided; recovery relies on Q3 validation that hasn't yet occurred
Project execution risk real: land acquisition, political approvals cause 1-2 year delays per management
Portfolio concentration in water/sanitation (majority); policy shift would hurt diversification thesis
Management held ₹3L Cr by 2030 guidance despite analyst pushback; signals internal caution on execution
Risks, ranked by how much they should concern a holder
Project execution delays
HIGHMOUs pledge ₹2L Cr but conversion to sanctions and disbursements hinges on land acquisition, social clearances, political approvals. Management itself acknowledged 1-2 year delays are routine. If ₹65k Cr FY27 target misses materially, the ₹3L Cr by 2030 thesis loses credibility.
Spreads compression persists beyond Q3
MEDIUMIf spreads stay at 1.8% or decline further, the 3% NIM thesis breaks. This is the single most important near-term claim to watch. Currently unproven; outcome determines profitability trajectory.
Interest rate tightening; RBI forex window closed or costs rise
MEDIUM₹1800 Cr+ raised via RBI forex window at 5.5-6.5% cost (1.5% hedging included). If RBI raises rates or closes the window, cost-of-funds rises, spreads compress further, and the recovery timeline extends.
Portfolio concentration in water/sanitation
MEDIUMMajority of portfolio is water, sanitation, drinking water (AMRUT priority). If Government shifts infrastructure priority to roads/metros/metros, growth diversification becomes slower and concentration risk re-prices.
Gross NPA ₹1600 Cr resolution drags beyond FY27
LOW₹1100 Cr in NCLT at advanced stage with lender consensus; some in consortium liquidation. Timing risk is real but severity is low given 55-year track record and robust provisioning (net NPA ₹82 Cr).
The debate
What to watch next
1 · Q3 FY27: Do spreads recover to 2%?
This is the most critical near-term proof point. Spreads recovery validates the NIM thesis and the growth-mix explanation. If spreads stay at 1.8% or move lower, the long-term profitability story weakens materially and patience for the ₹3L Cr by 2030 goal erodes.
2 · H2 FY27: Do Gujarat metro/road projects commence and disburse?
Management guided that Gujarat metro and road projects commence in H2, with first tranches likely. Visible disbursement proof from MOUs is the key test of execution capability. H2 disbursements need to exceed ₹25k Cr (implying ₹40k+ for H2 to hit ₹65k Cr annual target).
3 · FY27 full-year: ₹65k Cr disbursement execution + guidance trajectory
Board-approved borrowing is ₹70k Cr; sanction pipeline is ₹2.5L Cr. Hitting ₹65k Cr proves 30% acceleration is doable and builds credibility for long-term MOU execution. Mid-course FY28 guidance (or full-year FY27 review) will signal whether management upgrades ₹3L Cr by 2030 or holds (suggesting caution on execution).
HUDCO delivered a structurally sound quarter: YoY revenue +26.6%, FY27 guidance raised 30% to ₹65k Cr, ₹2L Cr+ MOU pipeline visible, and credit clean. But sequential PAT halved and spreads compressed vs. guidance—triggers that surface the core question: can HUDCO execute. The market's oversold technicals (RSI 27.9, -20.96% from ATH) suggest price opportunity, but holders need Q3 spreads recovery and H2 MOU disbursement proof before the ₹3L Cr by 2030 thesis shifts from structural play to near-term confidence.
The number to track from here is spreads. If Q3 validates 2% recovery, near-term visibility improves and the execution case hardens. If spreads stay compressed, profitability math deteriorates and execution risk gets re-priced lower. Until then, this is a steady structural opportunity priced for caution—credible on long-term structure, executing on near-term claims that need validation.
Informational and educational content only. Not investment advice.